publicações selecionadas
-
artigo académico
- Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP3R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3. International Journal of Molecular Sciences. 2023
- IP 3 R2 null mice display a normal acquisition of somatic and neurological development milestones. European Journal of Neuroscience. 2021
-
artigo de conferência
-
artigo de revista
- Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease. Molecular Neurobiology. 2019
-
documento
- The skeletal muscle in SCA3: contribution to disease, potential for biomarker development and therapeutic target 2023
- Assessing the HPA-axis mediated stress responses in a mouse model of SCA3 2023
- Motor coordination and balance ameliorated after treatment of the CMVMJD135 mouse model of Spinocerebellar Ataxia Type 3 with befiradol 2022
- Understanding the relevance of the cerebellar cognitive affective syndrome in SCA3 mice 2022
- Preclinical study of a 5-HT1A receptor specific agonist in the CMVMJD135 mouse model of Machado-Joseph disease. 2022
- The study of depression and cognitive comorbidities in a mouse model of spinocerebellar ataxia type 3 2022
- Pre and post-symptomatic treatment with NLX-112 improved the balance and motor coordination of the CMVMJD135 mouse model of Machado-Joseph Disease 2022
- Stress resilience in SCA3: study of depression and cognitive comorbidities in a mouse model 2022
- Preclinical study of a 5-HT1A receptor specific agonist in the CMVMJD135 mouse model of Machado-Joseph disease 2022
- Can chronic activation of serotonergic signalling be a therapeutic approach for neurodegenerative diseases? 2021
- Can chronic activation of serotonergic signalling be atherapeutic approach for neurodegenerative diseases? 2021
- NLX-112 improved the motor coordination and balance in a Mouse Experimental Model of Machado-Joseph Disease 2021
- Does activation of serotonergic treatment suppress proteotoxicity in mouse models of neurodegenerative diseases? 2021
- Do MJD mice present a cerebellar cognitive affective syndrome? 2021
- Towards the molecular determinants of serotonergic signaling-mediated suppression of SCA3 pathogenesis" 2021
- Impact of astrocytic calcium suppression in the pathogenesis of Machado-Joseph disease 2020
- Impact of astrocytic calcium suppression in the pathogenesis of Machado Joseph disease 2019
- Finding molecular determinants supporting serotonergic modulation as a therapeutic approach in Machado Joseph Disease 2019
- Early modulation of serotonergic signaling suppresses aggregation in Spinocerebellar Ataxia 3 2019
- Preclinical evidence supporting serotonergic modulation as a therapeutic approach for Spinocerebellar Ataxia 3 2019
- Finding molecular determinants supporting serotonergic modulation as a therapeutic approach in Machado-Joseph disease 2018
- Preclinical evidence supporting early initiation of citalopram treatment in Machado-Joseph disease 2018
- Serotonergic modulation of the proteostasis network and glutamatergic neurotransmission: impact on MJD 2017
-
teses